INTERNATIONAL PATENT: EVOX THERAPEUTICS LIMITED FILES APPLICATION FOR "CRISPR RNA MOLECULES FOR IMPROVED EV-MEDIATED DELIVERY OF CAS12 RNP COMPLEXES"

GENEVA, May 10 -- EVOX THERAPEUTICS LIMITED (Oxford Science ParkMedawar Centre, 2nd Floor East BuildingRobert Robinson AvenueOxford Oxfordshire OX4 4HG) filed a patent application (PCT/EP2025/081238) for "CRISPR RNA MOLECULES FOR IMPROVED EV-MEDIATED DELIVERY OF CAS12 RNP COMPLEXES" on Oct 29, 2025. With publication no. WO/2026/093377, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIANG, Xiuming (Terapivagen 14C, Lgh1701141 56 Huddinge, Stockholm), HOU, Wenqing (Karolinska InstitutetEl Andaloussi Lab/EvoxNovum/KFC BMM, ...